About this trial
The purpose of this study is to evaluate changes in self-reported wellbeing outcomes in adolescents. Bifidobacterium longum, 1714™ has previously been associated with beneficial effects on stress-related outcomes, sleep quality, subjective wellbeing and aspects of cognitive performance, however evidence in adolescents is limited. This study will evaluate changes in outcomes related to anxiety, sleep, fatigue, cognitive function and other wellbeing outcomes following daily consumption of Bifidobacterium longum, 1714™ under real-world conditions.
Eligibility criteria
Qualifiers
Aged 15-17 years at the time of study screening
Able and willing to provide informed consent or assent, with parental consent where applicable.
Enrolled in school or college at the time of screening
Participants must be able to read and understand English.
Disqualifiers
Pregnant, breastfeeding, or planning pregnancy during the study period
Known allergy or intolerance to any component of the study product
Pose a safety risk, or
Confound interpretation of study outcomes, as judged by the Investigator
Trial design
Treatments tested in this trial
- Bifidobacterium longum, 1714™